Brainlab recalled Spine & Trauma 3D Navigation 1.0 software manufactured and distributed between May 2018 and February 2019 due to the potential for incorrect information to display during surgery, preventing acccurate navigation of surgical tools inside the patient.
FDA has identified this as a Class I recall. Sixty devices were recalled in the U.S.
The software is used with Brainlab’s navigation system that provides patient images to navigate surgical tools and implants used before and during minimally invasive procedures. The potential for user misinterpretation could potentially cause damage to the patient, the need for a second surgical procedure or patient death.
Brainlab will cease distribution of this software once an updated version is available and released. On March 1, 2019, the company directed customers to avoid workflow changes with already registered datasets and offered directions on settings and attention to instructions and warnings in the user guide.
Source: FDA.gov
Brainlab recalled Spine & Trauma 3D Navigation 1.0 software manufactured and distributed between May 2018 and February 2019 due to the potential for incorrect information to display during surgery, preventing acccurate navigation of surgical tools inside the patient.
FDA has identified this as a Class I recall. Sixty devices were recalled...
Brainlab recalled Spine & Trauma 3D Navigation 1.0 software manufactured and distributed between May 2018 and February 2019 due to the potential for incorrect information to display during surgery, preventing acccurate navigation of surgical tools inside the patient.
FDA has identified this as a Class I recall. Sixty devices were recalled in the U.S.
The software is used with Brainlab’s navigation system that provides patient images to navigate surgical tools and implants used before and during minimally invasive procedures. The potential for user misinterpretation could potentially cause damage to the patient, the need for a second surgical procedure or patient death.
Brainlab will cease distribution of this software once an updated version is available and released. On March 1, 2019, the company directed customers to avoid workflow changes with already registered datasets and offered directions on settings and attention to instructions and warnings in the user guide.
Source: FDA.gov
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.